-
Economic Evaluation of Atogepant vs. Placebo for the Preventive Treatment of Episodic Migraine in Taiwan
Sep 9, 2025, 16:22 PM -
Cost Comparison of Alternative Delivery Routes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) in the English National Health Service (NHS)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of the Prostate Health Index (PHI) Test After a Prostate-Specific Antigen (PSA) Test in UK
Sep 9, 2025, 16:22 PM -
Clinical Outcomes Associated With Pembrolizumab Immunotherapy in Mesothelioma: A Systematic Review
Sep 9, 2025, 16:22 PM -
The Mediating Role of Insomnia in the Relationship Between Disease Severity and Mental Health Quality of Life and Productivity in Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ga-PSMA-11 PET/CT Imaging Followed by Lu-PSMA-617 vs. Standard of Care in Metastatic Castrate-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
Protocol for a Health Preference Study on Digital Health Interventions: Integrating DCE and BWS to Capture Subject, Interaction, System, and Societal Value
Sep 9, 2025, 16:22 PM -
Evolution of High-Efficacy Therapies for Relapsing Multiple Sclerosis: Does Innovation Meet Patient Preferences?
Sep 9, 2025, 16:22 PM -
The Next Steps Matter? New Cancer Medicines and Their Indication Extensions in Europe 2010-2020
Sep 9, 2025, 16:22 PM -
Assessing Pharmaceutical Innovation in Europe: Therapeutic Advances vs. Unmet Public Health Need
Sep 9, 2025, 16:22 PM -
Introducing the Parameter Outcome Overview Plot: A New Addition to the Sensitivity Analysis Armory for Economic Models
Sep 9, 2025, 16:22 PM -
Clinical Burden and Transfusion-Related Outcomes in Transfusion-Dependent Thalassemia in the Kingdom of Saudi Arabia and United Arab Emirates
Sep 9, 2025, 16:22 PM -
Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in China: Insights From CHOICE-CSU 2 Study
Sep 9, 2025, 16:22 PM -
How Impactful Is Time to Next Treatment on Health Technology Assessment Outcomes in Indolent Cancers?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Sep 9, 2025, 16:22 PM -
The Role of Qualitative Research in Randomized Controlled Trials Involving Drugs and Medical Devices: A Systematic Mapping Review
Sep 9, 2025, 16:22 PM -
IMF: The Innovative Medicines Fund or the Interim Medicines Fund?
Sep 9, 2025, 16:22 PM -
Assessment of the Economic and Societal Impact of Cervical Cancer Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Evaluating the Repurposing Potential of Statins: Association Between Statin Use and Cognitive Decline in Patients With Mild-to-Moderate Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Real-World Costs of United States Patients With T1 Diabetes, Removing Misdiagnosed Patients, and Compared With Patients With T1D and (T1.5 or T2) Diabetes
Sep 9, 2025, 16:22 PM
